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Abstract— Objective: Several studies have associated 
codeletion of chromosome arms 1p/19q in low-grade gliomas 
(LGG) with positive response to treatment and longer 
progression free survival. Therefore, predicting 1p/19q status is 
crucial for effective treatment planning of LGG. In this study, we 
predict the 1p/19q status from MR images using convolutional 
neural networks (CNN), which could be a noninvasive alternative 
to surgical biopsy and histopathological analysis. Method: Our 
method consists of three main steps: image registration, tumor 
segmentation, and classification of 1p/19q status using CNN. We 
included a total of 159 LGG with 3 image slices each who had 
biopsy-proven 1p/19q status (57 nondeleted and 102 codeleted) 
and preoperative postcontrast-T1 (T1C) and T2 images. We 
divided our data into training, validation, and test sets. The 
training data was balanced for equal class probability and then 
augmented with iterations of random translational shift, rotation, 
and horizontal and vertical flips to increase the size of the 
training set. We shuffled and augmented the training data to 
counter overfitting in each epoch. Finally, we evaluated several 
configurations of a multi-scale CNN architecture until training 
and validation accuracies became consistent. Results: The results 
of the best performing configuration on the unseen test set were 
93.3% (sensitivity), 82.22% (specificity), and 87.7% (accuracy). 
Conclusion: Multi-scale CNN with their self-learning capability 
provides promising results for predicting 1p/19q status 
noninvasively based on T1C and T2 images. Significance: 
Predicting 1p/19q status noninvasively from MR images would 
allow selecting effective treatment strategies for LGG patients 
without the need for surgical biopsy. 
 
Index Terms—deep learning, 1p/19q codeletion, therapy 
response, gliomas, convolutional neural networks 
I. INTRODUCTION 
Magnetic resonance (MR) imaging is a non-invasive medical 
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imaging technique that provides outstanding soft tissue 
contrast and has become the standard imaging technique for 
brain tumor diagnosis [1]. Gliomas are the most frequent 
primary brain tumors originating in the brain [2]. World 
Health Organization (WHO) classifies them into four grades 
based on their aggressiveness. Low-grade gliomas (LGG), also 
named diffuse low-grade and intermediate-grade gliomas 
(WHO grades II and III), include oligodendrogliomas, 
astrocytomas, and oligoastrocytomas [3-5].  Compared to 
high-grade gliomas (HGG: WHO grade IV, glioblastoma), 
LGG are less aggressive tumors with better prognosis. A 
subgroup of LGG will progress to glioblastoma (HGG, grade 
IV), but other subgroups will progress slower or remain stable 
[4, 6-8]. In addition, some LGG are sensitive to therapy and 
their survival ranges from 1 to 15 years [6, 8]. Presently, 
treatment includes observation, surgery, radiotherapy, and 
chemotherapy either separately or in combination [4]. 
Although histopathological study is the gold standard for 
diagnosis and subsequent treatment planning, it is known that 
histopathological diagnosis lacks information about other 
tumor properties that can impact optimal therapy options. 
Therefore, other tests of LGG (e.g. molecular biomarkers 
testing) are also obtained to improve treatment planning. 
Several studies [9-12] have shown that codeletion of 1p/19q 
chromosome arms is a strong prognostic molecular marker for 
positive tumor response to chemotherapy and radiotherapy in 
LGG and associated with longer survival. Therefore, 
predicting 1p/19q status is crucial for effective treatment 
planning of LGG.  
Currently, determining 1p/19q status requires surgical 
biopsy typically followed by fluorescence in-situ hybridization 
(FISH) [13] to identify chromosomal deletion. Several studies 
have shown that imaging can predict 1p19q status from MR 
images or positron emission tomography (PET) images. Fellah 
et al. [9] presented univariate analysis and multivariate 
random forest models to determine 1p/19q status from 
multimodal MR images including conventional MR images, 
diffusion weighted imaging (DWI), perfusion weighted 
imaging (PWI), and MR spectroscopy. DWI, PWI, and MRI 
spectroscopy showed no significant difference between tumors 
with and without 1p/19q loss in their study.  They concluded 
that inclusion of DWI, PWI, and MR spectroscopy was not 
useful for determining 1p/19q status compared with 
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conventional MR images. Jansen et al. [10] presented 
detection of 1p/19q status from [18F] fluoroethyltyrosine-PET 
(FET-PET) images. They derived several biomarkers from 
PET images and correlated with 1p/19q status, and showed 
that these biomarkers do not reliably predict the status of 
1p/19q in individual patients. Iwadate et al. [11] studied 
detection of 1p/19q codeletion from 11C-methionine PET 
images and concluded that 11C-methionine PET might help 
discriminate tumors with and without 1p/19q codeletion 
preoperatively. Bourdillion et al. [12] presented prediction of 
anaplastic transformation in grade 2 oligodendrogliomas based 
on MR spectroscopy and 1p/19q status. They showed that 
choline/creatine ratio >2.4 was associated with the occurrence 
of anaplastic transformation in patients without 1p/19q 
codeletion. On the other hand, no anaplastic transformation 
was observed in patients with 1p/19q codeletion.  
In this study, we present a robust, and noninvasive method 
to predict the 1p/19q status of LGG from post-contrast T1 and 
T2 weighted MR images using convolutional neural networks 
(CNN). 
II. MATERIAL AND METHODS 
We use a combination of two commonly acquired image 
types, T2 and post-contrast T1 weighted images, as input to 
our classification algorithm. Figure 1 shows examples of LGG 
image characteristics in post-contrast T1 and T2 weighted 
images with and without 1p/19q codeletion. Our classification 
algorithm consists of several pre-processing steps:  Multi-
modal image registration, tumor segmentation, data 
normalization, and data augmentation. After applying pre-
processing steps to data, we use the segmented images to train 
a multi-scale CNN for prediction of 1p/19q status. A flowchart 
and implementation details of the multi-scale CNN are shown 
in Figure 2. 
 
 
 
Figure 1: An example of low-grade glioma with and without 1p/19q 
codeletion. Images a and b show T2 and post contrast T1 for nondeleted 
1p/19q. Images c and d show T2 and post contrast T1 for codeleted 1p/19q. 
A. Brain Tumor Data 
One hundred fifty nine (n=159) consecutive (01-Oct-2002 – 
01-Aug-2011) pre-operative LGG patients, with stereotactic 
MRI images, who had biopsy proven 1p/19q status consisting 
either no deletion or co-deletion, were identified from our 
brain tumor patient database at Mayo Clinic for this study.  
The data included 102 nondeleted and 57 codeleted LGG. The 
types of LGG were oligoastrocytoma (n = 97), 
oligodendrogliomas (n = 45), and astrocytomas (n = 17). In 
total, 477 slices (3 slices per LGG including one centered at 
the tumor ‘equator’ plus one slice above and below) were 
included for this study. Post-contrast T1 and T2 weighted 
images were available for all selected patients. Institutional 
Review Board (IRB) approval was obtained for this study and 
requirement for patient consent was waived.  
 All images were acquired for biopsy planning purposes, and 
so a very consistent scanning protocol was used, including 
3mm thick T2 images and 1mm thick axial spoiled-gradient 
recalled images all acquired at 1.5T or 3T on either General 
Electric Medical System (Waukeshaw, WI) or Siemens 
Medical System (Malvern, PA) scanner. 
B. Pre-processing  
Multi-modal Image Registration 
We registered post-contrast T1 weighted images to T2 
weighted images of the same patient by using the ANTs open 
source software library for image registration [14, 15]. We 
performed rigid registration using cubic b-spline interpolation 
and mutual information metric, which takes into account 
translational movements, to align our intra-patient images.  
Tumor Segmentation 
We used our semi-automatic LGG segmentation software to 
segment the tumors in 2D [16]. First, the user selects the slice 
where the area of the tumor appears largest, and then draws a 
region-of-interest (ROI) that completely encloses the tumor 
and some normal tissue. Second, a normal brain atlas [17] and 
post-contrast T1 weighted images are registered to T2 
weighted images. Third, the posterior probability of each 
pixel/voxel belonging to normal and abnormal tissues is 
calculated based on information derived from the atlas and 
ROI. Finally, geodesic active contours [18] use the probability 
map of the tumor to shrink the ROI until optimal tumor 
boundaries are found. With that, a morphological binary 
dilation of five pixels is applied to make sure boundaries are 
included in the tumor ROI.  
 
Data Normalization 
 After registration and segmentation steps, the dataset of raw 
MR image data is normalized to balance intensity values and 
narrow the region of interest. This step aims to finely tune the 
input information fed into the CNN. The normalization 
process begins with skull-stripping using Brain Extraction 
Tool (BET) [19] based on FSL library [20], then followed by 
standard scoring. Standard scores (also called z-scores) are 
calculated for each image by subtracting the mean of image 
intensities from an individual intensities and then dividing the 
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difference by the standard deviation of the image intensities (see Eq. 1).  
 
 
Figure 2: A flowchart of the multi-scale CNN architecture. Blue box is the input image. Yellow boxes are convolutional layers. Green boxes are rectified linear 
units (RELU), activations. Red Boxes are max pooling layers. Purple boxes are fully connected layers plus a softmax binary classifier. Cyan circle shows the 
output labels.
𝑧 =   𝑋 − 𝜇𝜎  
Eq.1 
 
where 𝑋 is image intensities, 𝜇 is mean of the image 
intensities, and 𝜎 is the standard deviation of the image 
intensities. 
 
Data Augmentation 
 
Using deep networks, in particular CNNs, there is a high 
susceptibility to overfitting. This is a direct result of the large 
number of network parameters relative to the number of 
features provided by the MR images. The number of features 
available from MR images may not be sufficient to provide 
sufficient learning and generalizability to the parameters in the 
network, hence the need to increase the number of MR 
images. One approach to address this is through artificially 
augmenting the dataset using label-preserving transformations 
[21]. This “data augmentation” consists of generating image 
translations, rotations, and horizontal and vertical flipping. We 
apply a random combination of these transformations on each 
image, hence creating “new” images. This multiplies our 
dataset by several fold and help reduce over-fitting.  
C. Convolutional Neural Networks 
 
Convolutional Neural Networks (CNN) is a type of feed-
forward artificial neural network for learning a hierarchical 
representation of image data [22]. Unlike a regular Neural 
Network, the layers of a CNN have neurons arranged in 3 
dimensions (width, height, and depth) and respond to a small 
region of the input image, called receptive field, instead of all 
of the neurons in a fully-connected manner. Each neuron 
learns to detect features from a local region the input image. 
This allows capturing features of local structures and 
preserving the topology of the input image. The final output 
layer will reduce the full image into a single vector of class 
scores, arranged along the depth dimension.  
The main types of layers needed to build a CNN deep 
learning system are: input layer, convolutional layer, 
activation layer, pooling layer, and fully connected layer. Most 
implementations have many of each type of layer, hence the 
title ‘deep’learning. Each layer is described in more detail. 
Input layer: This layer holds the raw pixels values of the 
input image after applied pre-processing steps.  
Convolutional layer: This layer is composed of several 
feature maps along the depth dimension, each corresponding 
to a different convolution filter. All neurons with the same 
spatial dimension (width and height) are connected to the 
same receptive filed in the input image or, generally, in the 
previous layer. This allows capturing a wide variety of 
imaging features. The depth of the layer, i.e. the number of 
convolution filters, defines the number of features that can be 
extracted from each input receptive field. Each neuron in a 
feature map shares exactly the same weights, which define the 
convolution filter. This allows reducing the number of 
weights, and thus increasing the generalization ability of the 
architecture.  
Activation layer: This layer applies an activation function to 
each neuron in the output of the previous layer. For example, 
rectified linear unit (RELU) where RELU(x)= max(0,x) is the 
most common activation function used in CNNs architectures 
and fires the real value of the output and thresholds at zero. 
This layer does not change the size of the previous layer. It 
simply replaces negative values with ‘0’. 
Pooling layer: Placed after an activation layer and this layer 
down-samples along spatial dimensions (width and height). It 
selects the invariant imaging features by reducing the spatial 
dimension of the convolution layer. The most popular type is 
max pooling, which selects the maximum value of its inputs as 
 4 
the output, thus preserving the most prominent filter 
responses. 
Fully connected layer: As with neural networks, this layer 
connects all neurons in the previous layer to this layer with a 
weight for each such connection. If used as the output, each 
output nodes represents the ‘score’ for each possible class. 
To allow learning of complex relationships and to achieve a 
more hierarchical representation of the input image, multiple 
convolutional-pooling layers are stacked to form a deep 
architecture of multiple nonlinear transformations. This allows 
learning a hierarchy of complex features carrying predictive 
power for image classification tasks. 
 
Multi-Scale CNN parameters 
 
In our study, we use a CNN architecture that consists of 
different sizes of convolutional filters to train on our dataset 
(see Figure 2). This can be considered as multi-scale CNN that 
learns global and local imaging features with different 
convolutional filter sizes and concatenates their output before 
the classification step. The parameters of each layer are seen 
in the boxes in Figure 2. For example, the size of the first 
convolutional layer in the first branch is 128x200x200 and 
corresponds to depth of layer, 128 filters, and size of filters 
200 by 200 in 2D spatial space (x, y). Default stride size is 1 
pixel in x and y. Specific strides for each layer are shown in 
the boxes. Since every tumor has a different shape and size, 
we embedded each 2D tumor slice into standard background 
(zero intensity level) of size 205 by 205 pixels, which is the 
smallest that encompasses the largest tumor size in our data 
set.  
 
 In our architecture, probability of tumor slices belonging to 
each class were computed with softmax classifier and the 
parameters of the CNN were updated by minimizing a 
negative log likelihood loss function [23]. We used a 
stochastic gradient descend (SGD) [24] algorithm with mini 
batches of 32 samples in our study. The SGD algorithm with 
mini batches is commonly used to train neural networks on 
large datasets because it efficiently finds good values without 
high computation or memory requirements. Specifically, only 
a small batch of training data at a time is used at each update 
of weights instead of using all training samples to compute the 
gradient of the loss function. The learning rate was initially set 
to 0.001 and decreased 50% at every 50 epoch. The training 
was stopped when the change in validation loss smaller 0.02 
for 10 consecutive epochs. 
III. IMPLEMENTATION AND EXPERIMENTS 
Implementation 
 
Our code is based on the Keras package [25], built on top of 
Theano library, a Python library. Keras can leverage Graphical 
Processing Units (GPUs) to accelerate the deep learning 
algorithms. We trained our CNN architecture on an NVIDIA 
GTX 970 GPU card. The training took about 10 minutes to 2 
days depending on the amount of the used data. For example, 
using 30-fold augmented data as the training data at each 
epoch took about 2 days to train the network. 
 
Experiments 
 
We divided our data (n=477 slices) into training and test 
sets. A total of 90 slices (45 nondeleted and 45 codeleted) 
were randomly selected from the data at the beginning, as a 
test set, and never seen by the CNN during the training. From 
the remaining data (n=387), 252 slices that were balanced for 
equal class probability (n = 126 codeleted + 126 nondeleted) 
were randomly selected at each epoch for training. Twenty 
percent of the training set was separated as validation set (n = 
68) during the training. The data augmentation was applied to 
the training set (n = 7560 for 30-fold augmentation) at each 
epoch to increase the training samples and achieve 
generalization ability. 
 
We used the performance of our CNN architecture on 
validation set to tune the hyper-parameters of the CNN. Since 
our architecture includes multi-size of convolutional filters 
and multi-branch CNN, it takes into account a range of values 
for hyperparameters in the architecture. For further tuning of 
hyperparameters, we first investigated the contribution of each 
image channel for prediction of 1p/19q status. Therefore we 
experimented three configurations of our multi-scale CNN 
based on combinations of input images without data 
augmentation, i.e. T1 only (Configuration 1), T2 only 
(Configuration 2), and T1 and T2 combined (Configuration 3). 
We selected the best configuration (Configuration 3) among 
these based on their performance on the test set. Next, we 
trained the best configuration from above with multiple folds 𝑘   ∈    {10,20,30} of data augmentation to tune the 𝑘 hyper-
parameter of the data augmentation. We also compared the 
performances of our CNN architecture using four different 
optimizers: SGD, root mean square propagation (RMSprop), 
improved adaptive gradient algorithm (AdaDelta), and 
adaptive moment estimation (Adam). Configuration 4 was 
defined as the one using the best performing parameters. For 
each configuration, sensitivity, specificity, and accuracy were 
computed as follows: 
 
Sensitivity or True Positive Rate (𝑇𝑃𝑅): 𝑇𝑃𝑅 =    𝑇𝑃𝑇𝑃 + 𝐹𝑁 
where TP is true positives, FN is false negatives 
 
Specificity (𝑆𝑃𝐶) or True Negative Rate: 
 𝑆𝑃𝐶 =    𝑇𝑁𝑇𝑁 + 𝐹𝑃 
where TN is true negatives, FP is false positives 
 
and accuracy (𝐴𝐶𝐶): 
 𝐴𝐶𝐶 =    𝑇𝑃 + 𝑇𝑁𝑇𝑃 + 𝐹𝑃 + 𝑇𝑁 + 𝐹𝑁 
 
 
 5 
IV. RESULTS 
The results (Figure 3) show that the multi-scale CNN is 
overfitting to the original (limited size) data, when data 
augmentation is not used, The accuracy approached 100% 
after 50 epochs for both the training and validation sets as 
seen in Figure 3 and Table 1 and 2, but remains below 80% 
for the test data (see Table 3). As seen in the Figure 4, the 
loss also stops decreasing after 150 epochs for both the 
training and validation sets. As seen in the Table 3, the 
performances of the CNN configurations without data 
augmentation are lower than the other configurations. 
 
 
Figure 3: Accuracy plots are shown for the training (left) and validation (right) 
sets on the original data. Blue line corresponds to the use of T1C and T2 
combined as the input image (configuration 3). Green line corresponds to the 
use of T2 only as the input image (configuration 2). Red line corresponds to 
the use of T1C only as the input image (configuration 1). 
 
 
Figure 4: Loss plots are shown for the training (left) and validation (right) sets 
on the original data. Blue line corresponds to the use of T1C and T2 combined 
as the input image (configuration 3). Green line corresponds to the use of T2 
only as the input image (configuration 2). Red line corresponds to the use of 
T1C only as the input image (configuration 1). 
 
 
Figure 5: Accuracy (left) and loss (right) plots are shown for the training of 
the best performing configuration (4) on the augmented data. 
 
 Data augmentation of original data with 𝑘=30-fold 
(𝐴𝐶𝐶 = 89.5) gave the better accuracy on the validation 
dataset compared to the ones using 𝑘=10-fold (𝐴𝐶𝐶 = 85.5) 
and 𝑘=20-fold (𝐴𝐶𝐶 = 83.3) augmentations. Compared to 
training on the data without augmentation as seen in Figure 3 
and 4, accuracy and loss in Figure 5 fluctuate and are noisier. 
As seen in Table 3, the performance of the CNN configuration 
4 using the data augmentation are higher than the ones using 
the original data. 
 
 The Configuration 4 using T1C and T2 combined as the 
input image with the 30-fold data augmentation and SGD 
optimizer gives the best performance on the test data. Figure 5 
shows the performance of the best performing CNN 
configuration 4 on the training data. Table 1, 2 and 3 shows 
the performances of the CNN configurations on the training, 
validation and test datasets.  Table 4 shows the performance of 
the best performing configuration using 4 different optimizers. 
Figure 6 shows the validation loss of the best performing 
configuration 4 on the validation set. 
 
 
Figure 6: Validation loss is shown on the validation set for the best 
performing configuration (configuration 4).  
 
Table 1: Statistics for Training Set 
Configurations Sensitivity Specificity Accuracy 
1 100.0% 100.0% 100.0% 
2 100.0% 100.0% 100.0% 
3 100.0% 100.0% 100.0% 
4 94.5% 92.7% 91.7% 
Table 1: The sensitivity, specificity, and accuracy for each configuration of 
multi-scale CNN for the training set. Configurations: 1- using T1C only and 
no augmentation (NA), 2-using T2 only and NA, 3: using T1C and T2 
combined (T1T2) and NA, 4-using T1T2 and 30-fold augmentation. 
 
Table 2: Statistics for Validation Set 
Configurations Sensitivity Specificity Accuracy 
1 100.0% 100.0% 100.0% 
2 100.0% 100.0% 100.0% 
3 100.0% 100.0% 100.0% 
4 89.7% 89.4% 89.5% 
Table 2: The sensitivity, specificity, and accuracy for each configuration of 
multi-scale CNN for the validation set. Configurations: 1- using T1C only and 
no augmentation (NA), 2-using T2 only and NA, 3: using T1C and T2 
combined (T1T2) and NA, 4-using T1T2 and 30-fold augmentation. 
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Table 3: Statistics for Test Set 
Configurations Sensitivity Specificity Accuracy 
1 80.0% 46.7% 63.3% 
2 86.7% 64.4% 75.6% 
3 84.4% 73.3% 78.9% 
4 93.3% 82.2% 87.7% 
Table 3: Table shows sensitivity, specificity, and accuracy for each 
configuration of multi-scale CNN for the test set. Configurations: 1- using 
T1C only and no augmentation (NA), 2-using T2 only and NA, 3: using T1C 
and T2 combined (T1T2) and NA, 4-using T1T2 and 30-fold AG and further 
training. 
 
Table 4: Statistics for Optimizers  
Configurations Sensitivity Specificity Accuracy 
SGD 93.3% 82.2% 87.7% 
RMSprop 84.4% 84.4% 84.4% 
AdaDelta 82.2% 84.4% 83.3% 
Adam 88.8% 82.2% 85.5% 
Table 4: The performance of Configuration 4 with four different optimizers on 
the test dataset was shown.  
 
V. DISCUSSION 
In this study, we present a robust and noninvasive method 
to predict 1p/19q chromosomal arms deletion from post-
contrast T1 and T2 weighted MR images using multi-scale 
CNN approach. As mentioned in previous studies [4, 6-8], a 
subset of LGG are sensitive to therapy and have longer 
progress free survival while others may progress to HGG. 
Although histologic grade is the most important factor in 
therapeutic decision-making, it lacks information about other 
tumor properties that can impact optimal therapy options and 
recent reports suggest genomic marker may be more 
predictive than histologic grade [26]. Adding other 
information such as 1p/19 chromosomal arms deletion, which 
has been associated with positive response to therapy, could 
help improve therapeutic decision-making. 
An important challenge in applying deep learning methods 
to medical images is having an adequate number of data sets. 
Our multi-scale CNN had 100% sensitivity, specificity, and 
accuracy in training and validation sets without data 
augmentation (see Table 1 and 2: Configurations 1-3 and 
Figure 3), but had less than 80% specificity and accuracy for 
the (unseen) test set (see Table 3). This demonstrated that our 
algorithm did not truly learn the distinctive imaging features, 
but rather, overfit to the training examples. As seen in Table 3, 
configuration 4 using augmented data to train our multi-scale 
CNN approach perform better than the other configurations on 
the unseen test dataset. Fluctuations as seen in Figure 5 are 
results of introducing new augmented training data at each 
epoch. As seen in the results, augmenting a randomly selected 
set of the original training data, which is described in the 
experiment section, at each epoch improves generalization 
ability of the multi-scale CNN and prevents overfitting. As 
seen in Table 3, configuration 4 yields the best performance 
on the test dataset. The performance of configuration 4 in the 
training and validation datasets is in the same order with its 
performance in the test dataset. This highlights the 
generalizability of configuration 4 and its minimal overfitting.  
The misclassification rate on the test dataset is about 11%. 
Some part of this error might be due to the error rate 
introduced by the FISH test that was used to determine the 
1p/19 status. Scheie et al. [13] showed that the reliability of 
FISH test was 95% and 87.5% for the detection of 1p and 19q 
deletions, respectively.  
As seen in Figure 6, the loss on validation dataset for 
configuration 4 stops fluctuating and stabilizes with slight 
changes after 400 epochs for several epochs. This means that 
the network not learning much any more and had converged to 
a steady state. As seen Table 4, SGD optimizer gave superior 
performance on the test dataset compared to other three 
optimizers.   
As mentioned before, Fellah et al. [9] presented the first 
study that determined the 1p/19q status from DWI, PWI, MR 
spectroscopy and conventional MR images. Their 
misclassification rates were 48% and 40% for using only the 
conventional MR images and using all multimodal images, 
respectively. Compared to their results, our best performing 
configuration (4) was superior, with 93.3% sensitivity, 82.2% 
specificity, and 87.7% accuracy in the unseen test dataset. 
Moreover, our data was evaluated in a larger dataset (159 
LGG vs. 50 LGG). To the best of our knowledge, our study is 
the first using the deep learning to predict 1p19q from MR 
images in LGGs. 
Although the original data size was limited, artificially 
augmenting data helped increase the volume of our data. It 
may be that further performance gains will be realized with 
larger patient populations with more heterogeneous data. 
Furthermore, including weight regularization such as L1 or L2 
in the network might improve generalizability of our 
networks. Further studies with larger patient populations are 
required to investigate these and confirm our current findings. 
VI. CONCLUSIONS 
Our multi-scale CNN approach provides promising results 
for predicting 1p/19q codeletion status noninvasively, based 
on post-contrast T1 and T2 images. Our presented method 
could be further improved and potentially used as an 
alternative to surgical biopsy and pathological analysis for 
predicting 1p/19q codeletion status. 
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